Pharmazac was awarded the Salus Index 2016 Active Business Awards
November 2, 2023Pharmazac Sintetica & Rokitan Cooperations
November 2, 2023Pharmazac Lab acquires GMP certificates

Pharmazac announces that its state-of-the-art Research and Development Lab at its headquarters received by the Greek Ministry of Health a GMP manufacturing license (clinical batches) for under development medicinal products for human use and a GMP certificate for quality-control (QC) release.
Related News
February 12, 2026
November 2, 2023
PharmaZac sponsors the medical book “Epilepsy and Movement Disorders”
PharmaZac sponsors the medical book “Epilepsy and Movement Disorders” of Dr. A. Alexoudi Neurologist Ph.D of National and Kapodistrian University of Athens and Dr. S. Gatzonis, […]
November 2, 2023
We are investing in our new pharmaceuticals manufacturing site.
Pharmazac is working on its latest investment a new site of 10.000 sq.m for pharmaceuticals manufacturing, in the industrial zone of Keratea near Athens area . […]
November 2, 2023
Pharmazac launched the new product Zaolin/Vinorelbin
Pharmazac launched the new product Zaolin/Vinorelbin the first generic version for oral use ( soft gelatin caps) in Greece. Zaolin/Vinorelbin is a chemotherapy drug used to […]
